Online Menopause Information–Seeking Search Patterns and Commercial Content Over 2 Decades - Report - MDSpire

Online Menopause Information–Seeking Search Patterns and Commercial Content Over 2 Decades

  • By

  • Francesca R. Farina

  • James W. Griffith

  • Stephanie S. Faubion

  • Martha Hickey

  • Sarah Lensen

  • Monica Christmas

  • June 4, 2026

  • 0 min

Share

Trends in Online Searches for Menopause Information and Commercial Content

Overview

This study analyzes 20-year trends in online searches related to menopause, revealing a significant increase in the commercialization index across the US, UK, and Australia. The findings indicate a shift towards commercial content in menopause-related searches, raising concerns about the promotion of products with limited evidence of efficacy.

Background

Menopause is a significant health transition for women, often accompanied by various symptoms that can impact quality of life. As public interest in menopause has grown, there has been an increase in commercial offerings related to menopause management. Understanding trends in online searches can provide insights into public interest and the potential influence of commercial content on health information-seeking behavior.

Data Highlights

CountryCommercialization Index (2010)Commercialization Index (2025)
US0.220.37
UK0.160.36
Australia0.140.33

Key Findings

  • The commercialization index for menopause-related searches increased by 15 to 20 percentage points from 2010 to 2025 across the US, UK, and Australia.
  • In the US, the commercialization index rose from 0.22 to 0.37, while in the UK it increased from 0.16 to 0.36, and in Australia from 0.14 to 0.33.
  • Monthly increases in the commercialization index were consistent, with rates of 0.0008 in the US, 0.0006 in the UK, and 0.0006 in Australia.
  • Informational menopause searches grew faster than commercial searches, indicating a change in the relative composition of search interest rather than a displacement of information seeking.
  • Exploratory analyses suggested that increases in search interest accelerated in the UK and Australia after 2018, leading to convergence in trends across countries.

Clinical Implications

Healthcare professionals should be aware of the increasing commercialization of menopause-related information online, which may influence patients' perceptions and choices regarding menopause management. It is essential to guide patients towards evidence-based resources amidst the growing commercial content.

Conclusion

The study highlights a notable shift towards commercial content in menopause-related online searches over the past two decades, emphasizing the need for critical evaluation of the information patients encounter.

Related Resources & Content

  1. Journal of Medical Internet Research, 2026 -- Women’s Engagement With Different Internet-Enabled Technologies to Access Digital Menopause Information
  2. conexiant, 2026 -- Rethinking Menopause Hormone Therapy
  3. The Journal of Clinical Endocrinology & Metabolism, 2026 -- Discrepancies in Online Resources and Clinical Guidelines for Male Hypogonadism: A Comprehensive Multilingual Content Review
  4. Stat News, 2026 -- The rise of perimenopause misinformation
  5. NICE, 2026 -- Menopause: identification and management
  6. Overview | Menopause: identification and management | Guidance | NICE
  7. Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025)
  8. Recommendation: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions
  9. https://www.ese-hormones.org/media/22whfkd5/press-release-menopause-guideline-22october2025.pdf
  10. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials | Breast Cancer | JAMA | JAMA Network
  11. Researchers review findings and clinical messages from the Women’s Health Initiative 30 years after launch | National Institutes of Health (NIH)
  12. Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials | Journal of Clinical Oncology
  13. FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause
  14. Elinzanetant for Vasomotor Symptoms Associated With Menopause
  15. Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-analysis - PubMed
  16. FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies | FDA

Original Source(s)

Related Content